InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
44%
T+90 mean return
+15.3%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Vig Pamela, Directeur Scientifique. Officer active across 1 company, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 19 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €125k. History available since 10 May 2021. The latest transaction was filed on 24 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
30,559 shares@ US$2.93628.9% of flowCommon StockSEC:0001415889-24-018159:0
94 shares@ US$21.0460.6% of flowCommon StockSEC:0001415889-24-013354:0
1,379 shares@ US$20.62239.2% of flowCommon StockSEC:0001415889-24-008320:0
1,214 shares@ US$26.191810.1% of flowCommon StockSEC:0001415889-24-002757:0
1,408 shares@ US$28.034312.5% of flowCommon StockSEC:0001415889-24-000882:0
527 shares@ US$22.2873.8% of flowCommon StockSEC:0001209191-23-055436:0
1,425 shares@ US$25.646611.6% of flowCommon StockSEC:0001209191-23-041337:0
684 shares@ US$16.92353.6% of flowCommon StockSEC:0001209191-23-030962:0
9,625 shares0Common StockSEC:0001209191-23-006305:0
660 shares@ US$17.0513.9% of flowCommon StockSEC:0001209191-22-056889:0
807 shares@ US$13.5660.0003% mcap23.0% of flowCommon StockSEC:0001209191-22-028725:0
10,000 shares0Common StockSEC:0001209191-22-002433:0
10,000 shares0Common StockSEC:0001209191-22-002433
768 shares@ US$13.5150.0002% mcap19.8% of flowCommon StockSEC:0001209191-21-064455:0
768 shares@ US$13.5150.0002% mcap51.5% of flowCommon StockSEC:0001209191-21-064455
8,125 shares0Common StockSEC:0001209191-21-058609:0
8,125 shares0Common StockSEC:0001209191-21-058609
699 shares@ US$14.620.0002% mcap18.7% of flowCommon StockSEC:0001209191-21-032166:0
699 shares@ US$14.6218.7% of flowCommon StockSEC:0001209191-21-032166
19 of 19 declarations
About Vig Pamela
Pamela Vig is the Chief Scientific Officer and Head of Research & Development at Mirum Pharmaceuticals, Inc. She is responsible for the company's research and development strategy. Her scientific expertise is essential for innovation and the development of new products.
